Company / Working Capital
Repligen Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.0B
FY2025
5-year range
$556.4M / $1.0B
FY2021-FY2025
Trend
+6.6%
vs FY2024
Sector context
#39 of 213
Health Care
What the data says
Repligen's working capital of $1.0B is higher than 82% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from $146M in FY2018 to $1.0B in FY2025.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +11.4%. Top quartile in the Health Care sector.
Improved from $946M to $1.0B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +19.0%
- 5-Year CAGR
- +11.4%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 213This company $1.0B Sector average $934.6M
▼
+7.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +11.4%, indicating consistent growth.
- In FY2025, working capital increased 6.6% year-over-year.
- Ranks #39 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2018.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | +6.6% |
| FY2024 | $939.3M | -0.8% |
| FY2023 | $946.4M | +59.3% |
| FY2022 | $593.9M | +6.7% |
| FY2021 | $556.4M | -4.6% |
| FY2020 | $583.4M | -1.7% |
| FY2019 | $593.5M | +306.8% |
| FY2018 | $145.9M | -32.9% |
| FY2017 | $217.6M | +33.4% |
| FY2016 | $163.1M | +93.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026